Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Morphology of Donor and Recipient Nerves Utilised in Nerve Transfers to Restore Upper Limb Function in Cervical Spinal Cord Injury.
Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis.
Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen.
Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.
Selective and compartmentalized myelin expression of HspB5.
Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity.
[Acute transverse myelitis in a traveler].
In Vivo Gene Transfer to Schwann Cells in the Rodent Sciatic Nerve by Electroporation.
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.
>CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal.
Products
Immunotherapy-responsive Allodynia due to Distal Acquired Demyelinating Symmetric (DADS) Neuropathy.
PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients.
Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis.
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Endocannabionoid System in Neurological Disorders.
Longitudinal changes in sickness absence and disability pension, and associations between disability pension and disease-specific and contextual factors and functioning, in people with multiple sclerosis.
Plasma exchange therapy for a severe relapse of Devic's disease in a pregnant woman: A case report and concise review.
Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation.
Peculiarities of Neurological Disorders and Study Designs.
Virtual reality in multiple sclerosis - A systematic review.
What is the future of proof of concept studies in multiple sclerosis?
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
Therapeutic antibodies for spinal cord injury.
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.

Pages